韩正会见丹麦诺和诺德公司董事会主席龙海歌

Core Viewpoint - The meeting between China's Vice President Han Zheng and Novo Nordisk's Chairman, Lars Rebien Sørensen, highlights the strong economic complementarity and cooperation prospects between China and Denmark, particularly in the biopharmaceutical sector [1] Group 1: Economic Cooperation - Han Zheng emphasized the importance of enhancing mutual cooperation between China and Denmark, as well as the broader EU, to contribute to friendly relations and mutual benefits [1] - The Chinese government is committed to deepening reforms and expanding high-level opening-up, which will provide significant growth opportunities for global companies, including Novo Nordisk [1] Group 2: Health and Investment - China prioritizes public health development, aiming to establish the world's largest and most comprehensive basic medical insurance network, which has led to an increase in life expectancy [1] - Novo Nordisk expressed its intention to deepen its market presence in China and increase investments, aiming for mutual benefits in the partnership [1]